HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alexander Turchin Selected Research
Alexander Turchin Research Topics
Disease
5
Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 02/2015
4
Hypoglycemia (Reactive Hypoglycemia)
01/2021 - 02/2008
4
Hypertension (High Blood Pressure)
02/2015 - 12/2009
3
Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2016
3
Hyperglycemia
01/2021 - 02/2008
3
Diabetes Mellitus
01/2020 - 02/2008
3
Stroke (Strokes)
05/2018 - 01/2017
3
Coronary Artery Disease (Coronary Atherosclerosis)
05/2018 - 01/2016
2
Myocardial Infarction
01/2020 - 01/2018
2
Atrial Fibrillation
07/2017 - 01/2017
2
Neoplasms (Cancer)
10/2016 - 01/2015
2
Chronic Renal Insufficiency
02/2015 - 12/2014
1
Weight Loss (Weight Reduction)
01/2021
1
Diabetic Nephropathies (Diabetic Nephropathy)
01/2021
1
Insulin Resistance
01/2021
1
Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2021
1
Aortic Valve Stenosis (Aortic Stenosis)
11/2020
1
Unstable Angina
01/2020
1
Chest Pain (Chest Pains)
01/2020
1
Myalgia
05/2018
1
Muscular Diseases (Myopathy)
05/2018
1
Renal Insufficiency (Renal Failure)
01/2018
1
Calciphylaxis
08/2014
1
Hypoalbuminemia
01/2013
1
Hypercalcemia (Milk Alkali Syndrome)
01/2013
1
Hemorrhage
01/2011
1
Drug-Related Side Effects and Adverse Reactions
04/2009
1
Confusion (Bewilderment)
11/2006
1
Inflammation (Inflammations)
07/2006
1
Fibrosis (Cirrhosis)
07/2006
Drug/Important Bio-Agent (IBA)
5
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
03/2022 - 01/2016
4
Insulin (Novolin)
FDA Link
01/2021 - 05/2013
2
Biomarkers (Surrogate Marker)
IBA
11/2021 - 01/2015
2
Calcium
IBA
01/2021 - 08/2014
2
Anticoagulants
IBA
07/2017 - 01/2017
2
Lipids
IBA
12/2014 - 12/2009
2
Antihypertensive Agents (Antihypertensives)
IBA
05/2014 - 02/2008
2
Warfarin (Coumadin)
FDA Link
Generic
01/2013 - 01/2011
2
Glucose (Dextrose)
FDA Link
Generic
09/2011 - 02/2008
1
Nonesterified Fatty Acids (NEFA)
IBA
01/2021
1
Angiotensin II
IBA
01/2021
1
Advanced Glycation End Products
IBA
01/2021
1
Lipoprotein(a)
IBA
11/2020
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2020
1
Angiotensin Receptor Antagonists
IBA
01/2020
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2018
1
Hormones (Hormone)
IBA
10/2016
1
Hydrocortisone (Cortisol)
FDA Link
Generic
10/2016
1
antineoplaston A10 (A 10)
IBA
02/2015
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2015
1
1 alpha-hydroxyergocalciferol (doxercalciferol)
FDA Link
01/2013
1
paricalcitol (Zemplar)
FDA Link
01/2013
1
Calcitriol (Calcijex)
FDA Link
Generic
01/2013
1
Hemoglobins (Hemoglobin)
IBA
09/2011
1
Cholesterol
IBA
09/2011
1
LDL Lipoproteins (beta Lipoproteins)
IBA
09/2011
1
LDL Cholesterol
IBA
09/2011
1
oxidized low density lipoprotein
IBA
09/2011
1
Hypoglycemic Agents (Hypoglycemics)
IBA
02/2008
1
Aldosterone
IBA
07/2006
Therapy/Procedure
10
Therapeutics
03/2022 - 05/2013
3
Glycemic Control
01/2021 - 01/2018
1
Patient Readmission
01/2020
1
Cardiac Rehabilitation
01/2020
1
Renal Dialysis (Hemodialysis)
08/2014
1
Medication Reconciliation
04/2009
1
Patient Admission (Patient Admissions)
02/2008
1
Medication Errors (Medication Error)
11/2006